Broadleaf Partners LLC Has $9.49 Million Position in Intuitive Surgical, Inc. $ISRG

Key Points

• Broadleaf Partners LLC has reduced its stake in Intuitive Surgical by 20.7%, holding now 19,161 shares worth approximately $9.49 million, making it the firm’s 15th largest investment.
• Several major institutional investors have significantly increased their holdings in Intuitive Surgical, including GAMMA Investing LLC, which boosted its position by over 54,000% to a total value of around $15 billion.
• Analysts' outlook on Intuitive Surgical is largely positive, with a consensus rating of "Moderate Buy" and a price target averaging $595.95, as highlighted by multiple investment firms.

Broadleaf Partners LLC lessened its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 20.7% during the first quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 19,161 shares of the medical equipment provider's stock after selling 4,997 shares during the period. Intuitive Surgical accounts for about 2.5% of Broadleaf Partners LLC's portfolio, making the stock its 15th largest position. Broadleaf Partners LLC's holdings in Intuitive Surgical were worth $9,490,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors also recently modified their holdings of ISRG. Nuveen LLC acquired a new position in shares of Intuitive Surgical during the 1st quarter valued at $1,715,899,000. GAMMA Investing LLC lifted its position in shares of Intuitive Surgical by 54,010.7% during the 1st quarter. GAMMA Investing LLC now owns 3,028,576 shares of the medical equipment provider's stock valued at $14,999,630,000 after acquiring an additional 3,022,979 shares during the period. Goldman Sachs Group Inc. lifted its position in shares of Intuitive Surgical by 26.1% during the 1st quarter. Goldman Sachs Group Inc. now owns 2,819,666 shares of the medical equipment provider's stock valued at $1,396,496,000 after acquiring an additional 584,375 shares during the period. Northern Trust Corp lifted its position in shares of Intuitive Surgical by 15.8% during the 4th quarter. Northern Trust Corp now owns 3,619,293 shares of the medical equipment provider's stock valued at $1,889,126,000 after acquiring an additional 494,496 shares during the period. Finally, Wellington Management Group LLP lifted its position in shares of Intuitive Surgical by 15.0% during the 1st quarter. Wellington Management Group LLP now owns 3,499,052 shares of the medical equipment provider's stock valued at $1,732,975,000 after acquiring an additional 457,080 shares during the period. Institutional investors and hedge funds own 83.64% of the company's stock.

Wall Street Analyst Weigh In

A number of analysts have commented on ISRG shares. Citigroup restated a "buy" rating and set a $650.00 price target (up previously from $590.00) on shares of Intuitive Surgical in a research note on Thursday, May 22nd. Royal Bank Of Canada restated an "outperform" rating and set a $615.00 price target on shares of Intuitive Surgical in a research note on Tuesday, August 19th. BTIG Research boosted their price target on shares of Intuitive Surgical from $566.00 to $571.00 and gave the company a "buy" rating in a research note on Wednesday, July 23rd. Wall Street Zen upgraded shares of Intuitive Surgical from a "hold" rating to a "buy" rating in a research note on Saturday, July 26th. Finally, Deutsche Bank Aktiengesellschaft lowered shares of Intuitive Surgical from a "hold" rating to a "sell" rating and decreased their price target for the company from $515.00 to $440.00 in a research note on Monday, June 9th. Thirteen investment analysts have rated the stock with a Buy rating, six have issued a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and a consensus price target of $595.95.

Intuitive Surgical Price Performance

NASDAQ ISRG opened at $476.16 on Friday. Intuitive Surgical, Inc. has a 1 year low of $425.00 and a 1 year high of $616.00. The firm has a market cap of $170.69 billion, a price-to-earnings ratio of 66.41, a PEG ratio of 4.99 and a beta of 1.59. The company has a fifty day moving average price of $504.42 and a 200-day moving average price of $521.58.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last posted its earnings results on Tuesday, July 22nd. The medical equipment provider reported $2.19 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.93 by $0.26. Intuitive Surgical had a net margin of 28.51% and a return on equity of 14.56%. The firm had revenue of $2.44 billion during the quarter, compared to analyst estimates of $2.35 billion. During the same quarter in the prior year, the business posted $1.78 EPS. The business's revenue was up 21.4% compared to the same quarter last year. On average, research analysts anticipate that Intuitive Surgical, Inc. will post 6.43 EPS for the current fiscal year.

Insider Activity at Intuitive Surgical

In related news, SVP Mark Brosius sold 216 shares of the stock in a transaction dated Friday, June 6th. The shares were sold at an average price of $563.11, for a total transaction of $121,631.76. Following the completion of the transaction, the senior vice president owned 907 shares in the company, valued at approximately $510,740.77. This represents a 19.23% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, EVP Myriam Curet sold 4,500 shares of the stock in a transaction dated Friday, July 25th. The shares were sold at an average price of $492.48, for a total transaction of $2,216,160.00. Following the transaction, the executive vice president owned 353 shares of the company's stock, valued at approximately $173,845.44. The trade was a 92.73% decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 15,839 shares of company stock worth $7,896,972. 0.70% of the stock is owned by company insiders.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.